Bioceres Crop Solutions Corp - BIOX STOCK NEWS

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) reported a strong fiscal third quarter with a 35% YoY revenue increase to $35 million, driven by crop nutrition growth, particularly a 466% spike in micro-beaded fertilizer sales. The company is progressing on HB4 wheat with over 60,000 hectares contracted for planting. Adjusted EBITDA rose 163% to $6.9 million, reflecting improved margins. Despite some declines in crop protection revenue, total revenue for the trailing twelve months increased 12% to $177 million. Bioceres is also focused on sustainable practices and has partnered with Havanna for HB4 wheat-derived products.

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) has signed a definitive agreement with Havanna SA to provide HB4 wheat-based sustainable products to customers in Brazil and Argentina. This initiative aims to offer food products with a lower carbon footprint while preserving native ecosystems. The HB4 wheat technology enhances yields by 20% and increases CO2 sequestration by up to 7% during droughts. The agreement supports Bioceres’ commitment to sustainable agriculture, backed by its Generation HB4 program, which ensures full traceability and climate data secured on blockchain technology.

Bioceres Crop Solutions Corp. (NASDAQ: BIOX) announced its new listing on the Nasdaq Global Select Market and will participate in the bell-ringing ceremony on April 27, 2021. CEO Federico Trucco will lead the event, discussing the company’s role in advancing sustainable agriculture and CO2 sequestration through innovative technologies. The company’s HB4 program aims to enhance drought tolerance in crops while supporting food affordability and sustainability. Bioceres continues to push for environmentally friendly practices in agriculture.

Bioceres Crop Solutions Corp. (NYSE American: BIOX) is scheduled to hold a conference call on May 13, 2021, at 8:30 a.m. EDT to discuss its fiscal Q3 results for the period ending March 31, 2021. The call will feature Bioceres' leadership, including Chairman & CEO Federico Trucco. Investors can access the call via toll-free and international numbers or join the live webcast. A replay will be available until May 18, 2021. Bioceres focuses on crop productivity solutions that promote sustainable agricultural practices.

Bioceres Crop Solutions Corp. (NYSE American: BIOX) announced its voluntary transfer to the Nasdaq Global Select Market, set to begin trading on April 27, 2021. This transition aims to enhance awareness of its Agriculture Technology solutions focusing on sustainability and carbon neutrality. CFO Enrique Lopez Lecube highlighted the alignment with Nasdaq’s ESG initiatives, while Nasdaq's President, Nelson Griggs, welcomed Bioceres for its commitment to sustainable practices. The company's stock will retain its existing symbol 'BIOX' throughout this change.

Bioceres Crop Solutions Corp. (NYSE American: BIOX) has announced a definitive agreement to acquire a 6% ownership stake in Moolec Science Ltd., a company specializing in molecular farming for animal-free food production. This strategic partnership aims to enhance Bioceres' exposure to the rapidly growing alternative protein market, which was valued at USD $14.95 billion in 2019. Moolec's innovations include the world’s first bovine protein from modified safflower grain, expected to lower production costs significantly.

Bioceres Crop Solutions Corp. (NYSE American: BIOX) will engage in two investor conferences in March 2021. The Virtual 33rd Annual ROTH Conference will take place on March 16, featuring CFO Enrique López Lecube in virtual 1x1 meetings. The Investor Summit: Q1 Virtual Summit is scheduled for March 25 at 2:30 pm ET, with a webcast available on the company's Investor Relations website. Bioceres aims to boost agricultural carbon neutrality through innovative crop productivity technologies.

Bioceres Crop Solutions Corp. (NYSE American: BIOX) announced the completion of a $26 million public offering of Series V corporate bonds by its subsidiary, Rizobacter Argentina S.A. The offering consisted of two tranches: Class A bonds worth $5.2 million, maturing in March 2022 at 0.98% interest, and Class B bonds totaling $20.8 million, maturing in March 2024 at 5.5% interest. Proceeds will support working capital and extend debt maturities, showcasing strong investor confidence in Bioceres' commercial progress and its commitment to advancing sustainable agriculture.

Bioceres Crop Solutions Corp. (NYSE American: BIOX) reported its fiscal Q2 results for 2021, with revenues of $47.7 million, down from $57.0 million YoY, largely due to drought impacts. However, comparable revenues rose 8% to $167.8 million. Bioceres achieved regulatory approval for its HB4 drought-tolerant wheat, marking a significant milestone as it is the first of its kind globally. Seed inventory is anticipated to cover 60,000 to 130,000 hectares for the upcoming season. The HB4 soybean program saw an impressive 867% surge in participating growers, highlighting strong market interest.